查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594548

营养基因组学市场：按产品、按应用划分 - 2025-2030 年全球预测

Nutrigenomics Market by Product (Reagents & Kits, Services), Application (Cancer, Cardiovascular Diseases, Obesity) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年营养基因体学市值为6.0918亿美元，预计到2024年将达到7.1529亿美元，复合年增长率为17.53%，到2030年将达到1887.63百万美元。

营养基因组学是营养学和基因组学交叉领域的一个快速发展的领域，它探索个体遗传差异如何影响饮食对健康的影响，以优化健康和预防疾病，提供个性化的饮食建议。营养基因组学的需求源于对个人化营养解决方案日益增长的需求，以应对肥胖、糖尿病和心臟病等全球健康挑战。最终用途广泛，包括健康和保健领域、製药和机能性食品行业。市场成长是由基因组研究的进步、消费者对个人化健康意识的提高以及基因检测技术的进步所推动的。此外，慢性文明病的增加强调了对个人化营养的需求，为营养基因组学的扩展创造了巨大的机会。鼓励公司投资研究合作和策略伙伴关係，以利用基因组学资料的潜力并开发新产品和服务。然而，伦理问题、基因检测的高成本、监管障碍、缺乏消费者理解是市场扩张的障碍。至关重要的是，公司应透过强调透明的资料实践、具有成本效益的解决方案和消费者宣传活动来培养信任和知识来解决这些限制。营养基因组学的创新前沿在于开发人工智慧主导的工具，分析遗传资料以提供可行的营养见解，整合微生物组和基因组学，并设计全面的健康管理解决方案。该市场充满活力，其特点是协作生态系统，其中生物技术公司、学术机构和医疗保健提供者建立伙伴关係，并努力将基因组见解转化为实际的、促进健康的应用。企业应该透过进行策略性投资、促进跨学科研究和利用巨量资料分析来利用这些趋势，以保持竞争力并推动营养基因组学的采用。

主要市场统计
基准年[2023] 60918万美元
预测年份 [2024] 71529万美元
预测年份 [2030] 1,887.63 百万美元
复合年增长率（%） 17.53%

市场动态：揭示快速发展的营养基因组学市场的关键市场洞察

供给和需求的动态交互作用正在改变营养基因组学市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 生活型态的改变以及肥胖和糖尿病人口的增加
    • 皮肤科应用不断增加
    • 个人化营养和食品安全评估的普及
  • 市场限制因素
    • 熟练医生短缺，治疗费用上涨
  • 市场机会
    • 增加对研发活动的投资
    • 将人工智慧和机器学习整合到医疗保健中
  • 市场挑战
    • 营养基因组学领域缺乏监管批准

波特的五力：驾驭营养基因体学市场的策略工具

波特的五力架构是了解营养基因体学市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解营养基因体学市场的外部影响

外部宏观环境因素在塑造营养基因组学市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解营养基因体学市场的竞争格局

对营养基因组学市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵营养基因组学市场供应商的绩效评估

FPNV 定位矩阵是评估营养基因体学市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製营养基因组学市场的成功之路

营养基因组学市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 生活型态的改变以及肥胖和糖尿病的盛行率
      • 皮肤科应用增加
      • 个人化营养和食品安全评估的爆炸性增长
    • 抑制因素
      • 熟练医生短缺，治疗费用上涨
    • 机会
      • 增加对研发活动的投资
      • 将人工智慧和机器学习整合到营养基因组学实践中
    • 任务
      • 营养基因组学领域缺乏监管核准
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章营养基因体学市场：副产品

  • 试剂和套件
  • 服务

第七章营养基因体学市场：依应用分类

  • 癌症
  • 心血管疾病
  • 肥胖

第八章美洲营养基因组市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区营养基因组市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的营养基因组市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • BASF SE
  • Cell-Logic Pty Ltd.
  • Danone SA
  • DSM Nutritional Products AG by Koninklijke DSM NV
  • Genova Diagnostics Inc.
  • Metagenics LLC
  • Nutrigenomix Inc.
  • Unilever PLC
Product Code: MRR-036C5CF3B557

The Nutrigenomics Market was valued at USD 609.18 million in 2023, expected to reach USD 715.29 million in 2024, and is projected to grow at a CAGR of 17.53%, to USD 1,887.63 million by 2030.

Nutrigenomics, a burgeoning field at the intersection of nutrition and genomics, explores how individual genetic differences can affect the way diets influence health, providing personalized dietary recommendations to optimize health and prevent disease. The necessity for nutrigenomics arises from the growing demand for personalized nutrition solutions to combat global health challenges such as obesity, diabetes, and heart disease. Applications include personalized diet plans, health supplements, and interventions targeting gene-diet interactions, while end-use spans health and wellness sectors, pharmaceuticals, and functional foods industries. Market growth is driven by advances in genomic research, increasing consumer awareness of personalized health, and technological advancements in genetic testing. Furthermore, the rise in chronic lifestyle diseases underscores the demand for personalized nutrition, creating a significant opportunity for nutrigenomics to expand. Companies are encouraged to invest in research collaborations and strategic partnerships to harness the potential of genomics data and develop new products and services. Nevertheless, challenges such as ethical concerns, high costs of genetic testing, regulatory hurdles, and limited consumer understanding pose barriers to market expansion. It is crucial for businesses to address these limitations by emphasizing transparent data practices, cost-effective solutions, and consumer education campaigns to foster trust and knowledge. The innovation frontier in nutrigenomics lies in the development of AI-driven tools for analyzing genetic data and providing actionable nutritional insights, microbiome integration with genomics, and devising comprehensive health management solutions. The market is dynamic, with a collaborative ecosystem marked by partnerships between biotechnology firms, academic institutions, and healthcare providers striving to translate genomic insights into pragmatic, health-enhancing applications. Companies should capitalize on these trends through strategic investments, fostering multidisciplinary research, and leveraging big data analytics to stay competitive and drive forward the adoption of nutrigenomics.

KEY MARKET STATISTICS
Base Year [2023] USD 609.18 million
Estimated Year [2024] USD 715.29 million
Forecast Year [2030] USD 1,887.63 million
CAGR (%) 17.53%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Nutrigenomics Market

The Nutrigenomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Changing lifestyle and prevalence of obese and diabetic population
    • Increasing applications in dermatology
    • Surge in personalized nutrition and evaluation of food safety
  • Market Restraints
    • Lack of skilled physicians and high cost of treatment
  • Market Opportunities
    • Rising investments for R&D activities
    • Integration of AI and ML in nutrigenomics practices
  • Market Challenges
    • Lack of regulatory approvals in the field of nutrigenomics

Porter's Five Forces: A Strategic Tool for Navigating the Nutrigenomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Nutrigenomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Nutrigenomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Nutrigenomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Nutrigenomics Market

A detailed market share analysis in the Nutrigenomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Nutrigenomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Nutrigenomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Nutrigenomics Market

A strategic analysis of the Nutrigenomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Nutrigenomics Market, highlighting leading vendors and their innovative profiles. These include BASF SE, Cell-Logic Pty Ltd., Danone SA, DSM Nutritional Products AG by Koninklijke DSM N.V., Genova Diagnostics Inc., Metagenics LLC, Nutrigenomix Inc., and Unilever PLC.

Market Segmentation & Coverage

This research report categorizes the Nutrigenomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Reagents & Kits and Services.
  • Based on Application, market is studied across Cancer, Cardiovascular Diseases, and Obesity.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Changing lifestyle and prevalence of obese and diabetic population
      • 5.1.1.2. Increasing applications in dermatology
      • 5.1.1.3. Surge in personalized nutrition and evaluation of food safety
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled physicians and high cost of treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising investments for R&D activities
      • 5.1.3.2. Integration of AI and ML in nutrigenomics practices
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of regulatory approvals in the field of nutrigenomics
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Nutrigenomics Market, by Product

  • 6.1. Introduction
  • 6.2. Reagents & Kits
  • 6.3. Services

7. Nutrigenomics Market, by Application

  • 7.1. Introduction
  • 7.2. Cancer
  • 7.3. Cardiovascular Diseases
  • 7.4. Obesity

8. Americas Nutrigenomics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Nutrigenomics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Nutrigenomics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. BASF SE
  • 2. Cell-Logic Pty Ltd.
  • 3. Danone SA
  • 4. DSM Nutritional Products AG by Koninklijke DSM N.V.
  • 5. Genova Diagnostics Inc.
  • 6. Metagenics LLC
  • 7. Nutrigenomix Inc.
  • 8. Unilever PLC

LIST OF FIGURES

  • FIGURE 1. NUTRIGENOMICS MARKET RESEARCH PROCESS
  • FIGURE 2. NUTRIGENOMICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NUTRIGENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NUTRIGENOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. NUTRIGENOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. NUTRIGENOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NUTRIGENOMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NUTRIGENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NUTRIGENOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NUTRIGENOMICS MARKET DYNAMICS
  • TABLE 7. GLOBAL NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NUTRIGENOMICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NUTRIGENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NUTRIGENOMICS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NUTRIGENOMICS MARKET SIZE, BY OBESITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. NUTRIGENOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. NUTRIGENOMICS MARKET, FPNV POSITIONING MATRIX, 2023